Wagner R - Search Results

1

HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.

García-Arriaza J, Perdiguero B, Heeney JL, Seaman MS, Montefiori DC, Yates NL, Tomaras GD, Ferrari G, Foulds KE, Roederer M, Self SG, Borate B, Gottardo R, Phogat S, Tartaglia J, Barnett SW, Burke B, Cristillo AD, Weiss DE, Lee C, Kibler KV, Jacobs BL, Wagner R, Ding S, Pantaleo G, Esteban M. García-Arriaza J, et al. Among authors: wagner r. J Virol. 2017 Apr 13;91(9):e02182-16. doi: 10.1128/JVI.02182-16. Print 2017 May 1. J Virol. 2017. PMID: 28179536 Free PMC article.

2

Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.

Wagner R, Fliessbach H, Wanner G, Motz M, Niedrig M, Deby G, von Brunn A, Wolf H. Wagner R, et al. Arch Virol. 1992;127(1-4):117-37. doi: 10.1007/BF01309579. Arch Virol. 1992. PMID: 1456888

3

Immunological reactivity of a human immunodeficiency virus type I derived peptide representing a consensus sequence of the GP120 major neutralizing region V3.

Wagner R, Modrow S, Böltz T, Fliessbach H, Niedrig M, von Brunn A, Wolf H. Wagner R, et al. Arch Virol. 1992;127(1-4):139-52. doi: 10.1007/BF01309580. Arch Virol. 1992. PMID: 1456889

4

Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles.

Wagner R, Deml L, Fliessbach H, Wanner G, Wolf H. Wagner R, et al. Virology. 1994 Apr;200(1):162-75. doi: 10.1006/viro.1994.1175. Virology. 1994. PMID: 7510434 Free article.

5

Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses.

Wagner R, Böltz T, Deml L, Modrow S, Wolf H. Wagner R, et al. J Gen Virol. 1993 Jul;74 ( Pt 7):1261-9. doi: 10.1099/0022-1317-74-7-1261. J Gen Virol. 1993. PMID: 7687647 Free article.

6

Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).

Osterrieder N, Wagner R, Brandmüller C, Schmidt P, Wolf H, Kaaden OR. Osterrieder N, et al. Among authors: wagner r. Virology. 1995 Apr 20;208(2):500-10. doi: 10.1006/viro.1995.1181. Virology. 1995. PMID: 7747423 Free article.

7

Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.

Wagner R, Deml L, Schirmbeck R, Reimann J, Wolf H. Wagner R, et al. Behring Inst Mitt. 1994 Dec;(95):23-34. Behring Inst Mitt. 1994. PMID: 7755506 Review.

8

Identification of a region in the Pr55gag-polyprotein essential for HIV-1 particle formation.

von Poblotzki A, Wagner R, Niedrig M, Wanner G, Wolf H, Modrow S. von Poblotzki A, et al. Among authors: wagner r. Virology. 1993 Apr;193(2):981-5. doi: 10.1006/viro.1993.1210. Virology. 1993. PMID: 8460500

9

Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles.

Wagner R, Deml L, Schirmbeck R, Niedrig M, Reimann J, Wolf H. Wagner R, et al. Virology. 1996 Jun 1;220(1):128-40. doi: 10.1006/viro.1996.0293. Virology. 1996. PMID: 8659105 Free article.

10

A recombinant HIV-1 virus-like particle vaccine: from concepts to a field study.

Wagner R, Deml L, Teeuwsen V, Heeney J, Yiming S, Wolf H. Wagner R, et al. Antibiot Chemother (1971). 1996;48:68-83. doi: 10.1159/000425160. Antibiot Chemother (1971). 1996. PMID: 8726508 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,015 results

Search Page